Status:
COMPLETED
Use of Tranexamic Acid in Liposculpture
Lead Sponsor:
Total Definer Research Group
Conditions:
Blood Loss, Surgical
Eligibility:
All Genders
20-45 years
Phase:
PHASE2
PHASE3
Brief Summary
Blood loss during a surgical procedure is inevitable, its reduction is a key factor for surgical success. Also, to avoid progress to severe complications like hemodynamic decompensation, cardiac arres...
Detailed Description
In 3 plastic surgery centers, the investigators randomized patients in a double-blind, randomized, controlled trial comparing the clinical outcomes of different administration routes of TXA, intraveno...
Eligibility Criteria
Inclusion
- Patients that underwent liposculpture as unique procedure, surgical time between 2 and 5 hours, age between 20 and 45 years old and BMI between 20 and 30 m2/kg.
Exclusion
- Patients that were operated of liposculpture and any additional procedure (Mammoplasty, tummy tuck, etc.), patients with history of thromboembolic disease or in Treatment with aspirin within 14 days before surgery or anticoagulants within 5 days prior to surgery, patients with history of epilepsy, patients with allergy to tranexamic acid, comorbidity grade III or IV according to ASA (American society of Anesthesiologists) and patients with prothrombin time (PT) and/or activated partial thromboplastin time (aPTT) \>1.5 times the baseline.
Key Trial Info
Start Date :
January 17 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 22 2020
Estimated Enrollment :
141 Patients enrolled
Trial Details
Trial ID
NCT04430777
Start Date
January 17 2019
End Date
February 22 2020
Last Update
June 12 2020
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Dhara clinic
Bogotá, Colombia
2
Innovare hospital
Jalisco, Mexico
3
Centro Medico de las Americas clinic
Mérida, Mexico